Source: MarketScreener

Alcyone: Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx System Breakthrough Device

(marketscreener.com) LOWELL, Mass., Dec 2, 2019 /PRNewswire/ -- Alcyone Lifesciences, Inc., a biotechnology company dedicated to precision administered genetic therapies to treat complex neurological and oncological conditions through the company's proprietary advanced precision delivery platforms, looks forward to attending the 9th Annual CureSMA Gala "Hope on...http://www.marketscreener.com/news/Bringing-Hope-to-Spinal-Muscular-Atrophy-SMA-Patients-with-the-Alcyone-Lifesciences-ThecaFlex-DRx--29668799/?utm_medium=RSS&utm_content=20191202

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
PJ Anand's photo - President & CEO of Alcyone Lifesciences, Inc.

President & CEO

PJ Anand

CEO Approval Rating

83/100

Read more